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http:WHAT THIS PAPER ADDS
This is the ﬁrst worldwide survey to show how patient related and duplex ultrasound related factors inﬂuence
management strategies in varicose veins patient (C2eC6). The identiﬁcation of these factors may contribute to a
more personalized approach in clinical practice.Objectives: This study evaluated how patient characteristics and duplex ultrasound ﬁndings inﬂuence
management decisions of physicians with speciﬁc expertise in the ﬁeld of chronic venous disease.
Methods: Worldwide, 346 physicians with a known interest and experience in phlebology were invited to
participate in an online survey about management strategies in patients with great saphenous vein (GSV) reﬂux
and reﬂuxing tributaries. The survey included two basic vignettes representing a 47 year old healthy male with
GSV reﬂux above the knee and a 27 year old healthy female with a short segment reﬂuxing GSV (CEAP
classiﬁcation C2sEpAs2,5Pr in both cases). Participants could choose one or more treatment options.
Subsequently, the basic vignettes were modiﬁed according to different patient characteristics (e.g. older age,
morbid obesity, anticoagulant treatment, peripheral arterial disease), clinical class (C4, C6), and duplex
ultrasound ﬁndings (e.g. competent terminal valve, larger or smaller GSV diameter, presence of focal dilatation).
The authors recorded the distribution of chosen management strategies; adjustment of strategies according to
characteristics; and follow up strategies.
Results: A total of 211 physicians (68% surgeons, 12% dermatologists, 12% angiologists, and 8% phlebologists)
from 36 different countries completed the survey. In the basic case vignettes 1 and 2, respectively, 55% and 40%
of participants proposed to perform endovenous thermal ablation, either with or without concomitant
phlebectomies (p < .001). Looking at the modiﬁed case vignettes, between 20% and 64% of participants
proposed to adapt their management strategy, opting for either a more or a less invasive treatment, depending
on the modiﬁcation introduced. The distribution of chosen management strategies changed signiﬁcantly for all
modiﬁed vignettes (p < .05).
Conclusions: This study illustrates the worldwide variety in management preferences for treating patients with
varicose veins (C2eC6). In clinical practice, patient related and duplex ultrasound related factors clearly inﬂuence
therapeutic options.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Treatment strategiesINTRODUCTION
Numerous successful treatment options are available for
patients with uncomplicated and complicated varicose
veins. These treatment options include thermal, chemical,
or surgical ablation of the reﬂuxing saphenous trunk(s) withrresponding author. S.K. van der Velden, Department of Derma-
Erasmus MC, Burgemeester s’ Jacobplein 51, 3015 CA Rotterdam,
therlands.
il address: s.vandervelden@erasmusmc.nl (S.K. van der Velden).
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//dx.doi.org/10.1016/j.ejvs.2014.11.006or without high ligation, phlebectomies or (foam) sclero-
therapy of reﬂuxing tributaries, and combinations of the
above. As a result of the many available options, physicians
may treat patients in many different ways. This may also
cause some difﬁculties in selecting the best management
strategy. Physicians have to decide whether to proceed to a
more or less invasive treatment, or even refrain from
treatment. Several factors will inﬂuence this decision:
experience and preference of the physician, presence of
symptoms, health related quality of life (HRQoL), severity of
the chronic venous disease (CVD) and other patient related
and duplex ultrasound (DUS) characteristics, as well as
214 S.K. van der Velden et al.patient’s preference.1,2 Physicians obviously need to eval-
uate both the potential risks and beneﬁts of any treatment
they are considering, as well as the costs.3
To determine a proper management strategy in patients
with CVD, physicians are usually referred to current guide-
lines like those of the Society for Vascular Surgery and the
American Venous Forum.4 They clearly state that “the sci-
entiﬁc evidence must be combined with the physician’s
clinical experience to select the best treatment option for
each individual patient.”4e6 Apart from guidelines, there are
not many other useful tools available for assisting physi-
cians to optimize their management strategy for the indi-
vidual patient.
The objective of this survey was to evaluate more
detailed criteria regarding patient characteristics, clinical
and DUS ﬁndings, which may inﬂuence management de-
cisions in patients presenting with uncomplicated or
complicated varicose veins.Figure 1. Overview of duplex ultrasound ﬁndings of basic case
vignettes 1 (V1) and 2 (V2). SFJ ¼ saphenofemoral junction.METHODS
Participants
The investigators contacted all national presidents of
member societies of the International Union of Phlebology
(Union Internationale de Phlébologie [UIP]), from 43
different countries between July and August 2013. World-
wide, these “key contacts” were asked to nominate 10e20
physicians (vascular surgeons, angiologists, dermatologists,
phlebologists) per country who were known to have an
interest in phlebology and had been performing varicose
vein treatments for at least 5 years. If the president of the
national phlebologic society could not be contacted,
another colleague from the same country was contacted.
Physicians were considered eligible if they were familiar
with the use of several currently used varicose veins
treatment techniques, including phlebectomies, one of the
techniques for endovenous thermal ablation (EVTA), and
ultrasound-guided foam sclerotherapy (UGFS). They were
also allowed to participate if they did not perform EVTA
themselves, but delegated this to a colleague when indi-
cated. The same was true for high ligation and stripping.
All nominated physicians were invited by email to com-
plete the online survey between January and March 2014.
The survey was available in English and Spanish.Survey
At the beginning of the survey, participating physicians
were asked for their specialty, their practice (which tech-
niques they perform themselves, and for which they refer a
patient to a colleague), years of experience in treating
phlebologic patients, country of education, and country of
present clinical practice.
The survey further included two basic case vignettes of
patients with great saphenous vein (GSV) reﬂux. Basic case
vignette (V1) reported the case of a 47 year old healthy man
(BMI 23.4 kg/m2) who presented with heaviness of the right
leg. Physical examination of the legs demonstrated varicoseveins without edema or skin changes on the right leg. DUS
examination (Fig. 1) revealed reﬂux from the terminal valve
at the saphenofemoral junction (SFJ) and GSV reﬂux above
the knee. The diameter of the GSV was 6 mm at mid-thigh
level. Reﬂuxing tributaries (largest diameter, 5 mm) were
seen at medial calf level. There was no GSV reﬂux below the
knee. The deep venous system was patent and competent.
The CEAP classiﬁcation was C2SEpAs2,5Pr.
Following the description of V1, participants were ﬁrst
asked which management strategy they would like to
perform in this patient. To answer this question, they were
able to choose one or more of the 10 proposed potential
answers, including EVTA, ligation and stripping, single
stripping (also called isolated stripping), UGFS of the GSV,
UGFS of the tributaries, concomitant phlebectomies, iso-
lated phlebectomies, CHIVA (Cure Hémodynamique de
l’Insufﬁsance Veineuse en Ambulatoire, a particular surgical
treatment based on hemodynamics),7 medical elastic
compression stockings (MECS), no treatment, or “other”, to
be speciﬁed by the respondent, if the preferred treatment
option was not one of the 10 above cited possibilities.
Subsequently, V1 was modiﬁed step by step, changing
complaints, patient characteristics, clinical ﬁndings and DUS
ﬁndings (Table 1). Participants were then asked whether
they would change their strategy for the modiﬁed case and,
if so, to indicate which treatment option(s) they would
prefer. Participants were also asked to determine cut off
values for GSV diameter, below which or above which they
would change their treatment strategy. Only cut off values
between 1e13 mm were further investigated in the survey.
After completion of the questionnaire concerning all the
modiﬁcations of V1, a second basic case vignette (V2) was
described: a 27 year old healthy female (BMI 23 kg/m2)
complaining of heaviness and fatigue of the left leg. She
presented with varicose veins in the medial thigh extending
to the calf, without edema or skin changes. DUS (Fig. 1)
revealed reﬂux of the GSV, from the terminal valve of the
Table 1. Modiﬁcations of basic case vignettes in the survey.
Case vignette 1 (C2SEpAs2,5Pr):
Complaints
Asymptomatic, only cosmetic concern
(C2AEpAs2,5Pr)
Patient characteristics
Older age >80 yrs
Gender: female
Peripheral arterial disease (ankle brachial index
<0.6)
High body mass index (>40 kg/m2)
Chronic oral anticoagulant treatment
Clinical ﬁndings:
Skin changes: pigmentation (C2,4aSEpAs2,5Pr)
Venous ulceration (C2,6SEpAs2,3,5Pr)
Duplex ultrasound ﬁndings
Competent terminal valve
Focal dilatation of GSV above knee (12 mm)
Small diameter of GSV (cut off value determined
by participant)
Large diameter of GSV (cut off value determined
by participant)
Case vignette 2 (C2SEpAs2,5Pr):
Duplex ultrasound ﬁndings:
Diameter of short reﬂuxing segment <5 mm
Diameter of short reﬂuxing segment >8 mm
Length of reﬂuxing GSV segment (cut off value
determined by participant)
Table 2. Characteristics of physicians participating in the survey.
Characteristics n (%)
Specialty
Surgeon (mostly vascular) 143 (68)
Dermatologist 26 (12)
Angiologist 25 (12)
Phlebologist 17 (8)
Management Strategies for Patients with Varicose Veins 215SFJ, to 17 cm below the SFJ. At this level, the GSV had a
large reﬂuxing tributary, while the GSV itself became very
small without any reﬂux. The diameter of the cranial
reﬂuxing GSV segment was 5 mm. CEAP classiﬁcation was
deﬁned as C2SEpAs2,5Pr.
Finally, participating physicians were questioned about
the timing of the ﬁrst follow up after the initial treatment
and whether they want to schedule further visits or not.
They were further asked to indicate which of the following
parameters would inﬂuence their management strategy for
persisting reﬂuxing tributaries after successful ablation of
the GSV: clinically visible or not, large or small diameter,
superﬁcial course or not, cosmetic complaints or not,
presence or absence of symptoms, and clinical class, ac-
cording to the CEAP classiﬁcation.Certiﬁed since
<10 years 25 (12)
10e20 years 72 (34)
>20 years 114 (54)
Continent of current clinical practice
Europe 147 (70)
Latin America 30 (14)
Asia 13 (6)
North America 10 (5)
Oceania 11 (5)
Techniques performed in own practice
EVTA 167 (79)
UGFS 182 (86)
Surgery 152 (59)
Phlebectomies 165 (78)
CHIVA 31 (15)
EVTA ¼ endovenous thermal ablation; UGFS ¼ ultrasound-guided
foam sclerotherapy; CHIVA¼ conservative hemodynamic treatment.Statistics
The McNemar test was used to compare paired proportions
of preferred treatment options between the basic vignettes
and modiﬁed vignettes. The Bonferroni test was used to
correct for multiple testing. The change in distribution of
management strategies between the basic case vignettes
and modiﬁed case vignettes was compared using the Stuart-
Maxwell test, which is used to compare paired proportions
with more than two categories.
To be included in the analysis a particular treatment
strategy had to be chosen by at least 5% of all respondents.
Options or combinations of options chosen by less than 5%
were summarized as “alternative” in the global analysis.
Multivariate logistic regression analysis investigated the
association between physicians’ characteristics and thepreferred treatment strategy (e.g. surgical vs. non-surgical).
Independent variables included time since certiﬁcation,
continent of clinical practice, and specialty. To prevent over-
ﬁtting, a limited number of independent variables were
included.
The Statistical Package for the Social Sciences (SPSS),
version 21.0 software (IBM, Armonk, NY, USA) was used for
data analysis. The distribution analyses were conducted
using available software (http://www.R-project.org).
RESULTS
A total of 211 specialists from 36 different countries
completed the survey (Table 2), resulting in a response rate
of 58%.
Basic case vignettes
Participants chose a variety of different strategies for both
V1 and V2 (Table 3). In V1 and V2, respectively 55% and
40% of participants proposed to perform EVTA, either with
or without concomitant phlebectomies (p < .001). In V2
11% preferred single phlebectomies as initial treatment,
compared with only 6% in V1 (p ¼ .01).
Multivariate logistic regression analysis only revealed a
signiﬁcant association between the duration since certiﬁ-
cation (<20 years) and a less invasive treatment strategy
(e.g. UGFS or EVTA of the GSV, conservative or no treat-
ment) (data not shown).
Modiﬁed case vignettes
The main results of the survey regarding changes in pro-
portion of the different management strategies in the
modiﬁed case vignettes are summarized in Figs. 2 and 3.
Table 3. Treatment strategies proposed by the participants for the
basic case vignettes (V1 and V2).
Treatment strategies V1, n (%) V2, n (%)
EVTA 43 (20) 16 (8)
EVTA þ phlebectomies 73 (35) 67 (32)
EVTA þ UGFS of tributaries 17 (8) 9 (4)
Ligation þ stripping þ phlebectomies 12 (6) 10 (5)
EVTA þ ligation 13 (6) 15 (7)
UGFS of GSV þ UGFS of tributaries 9 (4) 11 (5)
Single phlebectomies 5 (2) 23 (11)
Alternative 39 (19) 60 (28)
EVTA ¼ endovenous thermal ablation; UGFS ¼ ultrasound-guided
foam sclerotherapy; GSV ¼ great saphenous vein.
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change in distribution of management strategies between
the basic vignettes and modiﬁed vignettes was signiﬁcant.
Patient characteristics (Fig. 2)
Looking at the different patient characteristics (Table 1),
older age, peripheral arterial disease (PAD), and high body
mass index (BMI) were considered relevant in altering the
management strategy in respectively 61%, 64%, and 52% of
participants. In the vignettes with one of these three pa-
tient characteristics modiﬁed, a quarter of participants
proposed to convert their strategy into a less invasive
treatment, mainly consisting of fewer phlebectomies, more
UGFS of tributaries, and more MECS. In particular, in cases
of PAD “no treatment” became a frequently preferred op-
tion (20%). Physicians who indicated they would prescribe
MECS for patients with PAD as an alternative treatment
usually added this would be a “light” compression stocking.
Several participants answered they would ﬁrst opt for an
arterial revascularization. For patients with high BMI putting
them on a diet, in addition to other conservative measures
was often suggested. The use of oral anticoagulant treat-
ment (coumarin) was a reason for adapting the treatmentFigure 2. Inﬂuence of cosmetic complaints, patient characteristics an
represent the difference in distribution between vignette 1 and mod
measured using the Stuart-Maxwell test. cosm ¼ only cosmetic compl
AC ¼ anticoagulant treatment; fem ¼ female gender; EVTA ¼ endoven
guided foam sclerotherapy; GSV ¼ great saphenous vein; MECS ¼ mestrategy for 45% of participating specialists, and this mainly
consisted of avoiding phlebectomies. Female gender clearly
appeared to be less important for adapting the manage-
ment strategy, as only 26% of respondents stated they
would do so.Clinical ﬁndings
If the clinical class of V1 was modiﬁed from C2 (varicose
veins) to C4a (pigmentation), the preferred treatment
technique(s) did not change considerably. However, if the
patient suffered from venous ulceration (C6), with GSV
reﬂux extending down to the ankle, participants avoided
phlebectomies and were more likely to consider another
additional treatment (e.g. high ligation, UGFS of the GSV
below the knee and/or UGFS of tributaries).Duplex ultrasound ﬁndings
If the terminal valve was competent, fewer participants
would ablate or remove the reﬂuxing GSV. Instead, 13%
preferred single phlebectomies (p < .001).
Presence of a focal dilation of the GSV did not result in a
major shift of treatment strategy although the distribution
of treatments altered signiﬁcantly compared to the basic
vignette (p < .001).
A vast majority of respondents (74%) answered that vein
diameter was important for the treatment strategy. They
changed their management when the diameter of the GSV
was less than a median of 4 mm (interquartile range [IQR]
3e5) or above 10 mm (IQR 7e10). If the diameter of the
GSV was below 4 mm, 44% of participants indicated a
change to a less invasive treatment compared to V1. If the
diameter was above 10 mm, more EVTA with additional
high ligation or classic surgery was proposed, representing
31% of all options.
The patient of V2 had GSV reﬂux from the terminal valve,
only limited to a short segment of the GSV. If the diameterd clinical ﬁndings on management strategy (n ¼ 211). p-values
iﬁed vignettes (cosm, age, PAD, BMI, AC, fem, C4, C6) and were
aints; PAD ¼ peripheral arterial disease; BMI ¼ body mass index;
ous thermal ablation; phleb ¼ phlebectomies; UGFS ¼ ultrasound-
dical elastic compression stockings.
Figure 3. Inﬂuence of duplex ultrasound ﬁndings on management strategy. Note. p-values represent the difference in distribution between
vignette 1 and adapted vignettes (TV competence, focal dilation, small diameter, large diameter) or between vignette 2 and adapted
vignettes (segmental reﬂux with small diameter, segmental reﬂux with large diameter) and were measured using the Stuart-Maxwell test.
V1 ¼ basic case vignette 1; TV ¼ terminal valve; V2 ¼ case vignette 2; EVTA ¼ endovenous thermal ablation; phleb ¼ phlebectomies;
UGFS ¼ ultrasound-guided foam sclerotherapy; MECS ¼ medical elastic compression stockings. *N ¼ 155, small diameter was based on
the cut off value for diameter of the GSV below which participants would consider changing their treatment strategy (median 4 mm).
**N ¼ 138, large diameter was based on the cut off value for diameter of the GSV above which participants would consider changing their
treatment strategy (median 10 mm). For this question of the survey, small diameter of segmental reﬂuxing GSV was deﬁned as <5 mm by
the investigators. Large diameter of segmental reﬂuxing GSV was deﬁned as >8 mm.
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<5 mm, a change to a less invasive treatment was
observed. If the short segment had a diameter >8 mm,
participants less frequently selected single phlebectomies
(p < .001) and more often EVTA with or without phlebec-
tomies (p < .001).
Only 39% of the participants considered the length of
reﬂuxing trunk relevant for deciding whether or not to
ablate the trunk. They suggested a minimal length of at
least 10 cm (minimum 2 cm, maximum 45 cm).Follow-up and further treatment
Seventy-one per cent of participants replied they would
evaluate the immediate outcome of the proposed man-
agement strategy within 8 weeks after initial treatment. TheFigure 4. Reasons for further visits after initial follow up. Sys-
tematic was deﬁned as “I would schedule patients for further
follow up visits, irrespective of symptoms, physical and/or ultra-
sound examination.” DUS ¼ duplex ultrasound.majority claimed to continue follow-up thereafter for
various reasons (Fig. 4).
Over 60% of physicians proposed to treat persistent
reﬂuxing tributaries, in cases where there were symptoms,
cosmetic concerns, or visible tributaries (Fig. 5). Phlebec-
tomies seemed to be used as frequently as UGFS to treat
reﬂuxing tributaries. However, there was a preference for
phlebectomies in cases where tributaries had a large
diameter, a superﬁcial course, or where they were visible,
and a preference for UGFS in other cases (p < .001) (Fig. 5).DISCUSSION
The results of this survey ﬁrst of all illustrate that physicians
all over the world use many different management strate-
gies for treating patients with varicose veins. Second, EVTA
has become a very popular option for treating patients with
uncomplicated varicose veins with GSV reﬂux. Third, patient
characteristics, clinical ﬁndings and DUS ﬁndings inﬂuence
management decisions in patients presenting with varicose
veins, as expected.
The large diversity in treatment methods may be partially
explained by differences in available resources and/or
health care policies in different countries, for example
equipment, reimbursement of certain interventions, timing
(treatment only allowed in one session, or in multiple ses-
sions), and setting (hospital environment or private prac-
tice). However, when comparing the results among the
participating continents or specialties, no major differences
could be found. In 2006, a survey on the management of
varicose veins was distributed among the members of the
Vascular Society of Great Britain and Ireland. Only half of
the respondents offered the same range of treatment in
Figure 5. Inﬂuence of different characteristics of persisting reﬂuxing tributaries on the preferred management strategy. UGFS ¼ ultrasound-
guided foam sclerotherapy.
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This was mainly due to restrictions for the treatment of
varicose veins in their NHS practice.8
National and international guidelines for the manage-
ment of chronic venous disorders, have only become
available in recent years. Interestingly, the results of the
present survey revealed that participants use several single
or combined treatment strategies which are not cited in any
guideline, and are not supported by the literature, for
example adding high ligation to EVTA,9 and some of the
treatment strategies belonging to the ‘alternative’ group.
Probably, in varicose vein treatment, as in other specialties,
it might be useful to establish recommendations about “do
nots”, to avoid overuse or misuse of procedures, potentially
leading to harm or unnecessary health care spending. In the
United States, an interesting initiative has been launched in
2012 by the American Board of Internal Medicine Founda-
tion, who initiated the ‘Choosing wisely’ campaign (http://
choosingwisely.org) to improve appropriate and necessary
treatment. So far, about 60 specialty societies have pub-
lished a “List of Five Things Physicians and Patients Should
Question”, consisting of ﬁve recommendations about what
should not be done. Unfortunately as yet, no recommen-
dations have been made for “choosing wisely” in patients
with varicose veins.
The EVTA option was very popular in both basic case
vignettes. Nowadays, EVTA has largely replaced classic
surgery as the treatment of choice for the incompetent GSV,
and classic extensive surgery under general anesthesia can
no longer be considered the gold standard.10 After 100
years of status quo, it is surprising how fast minimally
invasive endovenous treatment methods have been
accepted worldwide.11
According to the survey, several patient characteristics
inﬂuenced management strategies, in particular older age,
concomitant PAD, high BMI, and oral anticoagulanttreatment. Older age resulted in a shift towards a less
invasive treatment, with more participants choosing UGFS,
MECS, or no treatment for uncomplicated varicose veins.
This seems logical, in view of comorbid conditions and often
limited mobility in elderly patients.
If severe PAD was present, participants were more likely
to adapt their treatment strategy to a more conservative
treatment (e.g. no treatment or light compression stock-
ings). It was quite surprising to ﬁnd several physicians
prescribing MECS in a patient with an ankleebrachial index
<0.6, although some of them clearly stated they would do
so only after arterial revascularization. Two prospective
studies reported a safe application of ‘modiﬁed’ compres-
sion therapy (not by means of stockings, but with inelastic
material and reduced compression pressure of 20e
30 mmHg) in patients with moderate PAD (ankle brachial
pressure index between 0.8 and 0.5).12,13 Nevertheless,
extreme caution is necessary when compression is applied
to legs with severe PAD to prevent skin necrosis.14
For patients with a high BMI, participants in the survey
more frequently suggested conservative measures, in
comparison to V1 (patient with a normal weight). Several
studies stated that patients with a higher BMI are more
likely to develop surgical site infections and anatomic fail-
ures after groin surgery or RFA.15,16 Hence it seems logical
to have these patients lose some weight before proceeding
to endovenous or surgical treatment of varicose veins. If the
patient was on chronic anticoagulant treatment, partici-
pants often avoided performing phlebectomies. In these
patients phlebectomies may indeed exceptionally lead to
major bleeding complications, in particular when large
tributaries and perforating veins are involved.17 Therefore,
it may be wise to limit the number of phlebectomies,
monitor INR, employ local anesthetic with adrenaline, or
even tumescent anesthesia.17 There are less concerns about
treating patients on anticoagulation with EVTA or UGFS.18,19
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intervention in the C2 patient of V1, it is not surprising to
see no real changes in management of a patient with C4a,
except for adding high ligation to truncal ablation. The same
was true for C6 patients, apart from the many alternative
options suggested by the participants.
DUS ﬁndings did alter treatment strategy, and it was
mainly the diameter of the reﬂuxing GSV trunk that was
considered relevant. The presence of a focal dilatation of
the trunk only led to minor changes in strategy in the
present survey. According to a recently published retro-
spective study, terminal valve incompetence, a greater
diameter of the GSV in the thigh, and the presence of a
focal dilatation of the GSV were found signiﬁcantly more
frequently in cases treated by ablation of the GSV than in
those treated with phlebectomies only (ASVAL
method ¼ ambulatory selective varices ablation under local
anesthesia).20
GSV diameter was considered important in management
decisions. Large diameter GSVs are almost always associ-
ated with terminal valve incompetence at the SFJ, and are
related to increased hemodynamic impairment and higher
C-class (C4eC6).21,22 Recently, a randomized controlled
trial, comparing UGFS with classic surgery, showed that
patients with a large diameter GSV and distal GSV reﬂux at
baseline had a higher probability of failure after UGFS.23
On the other hand, according to several retrospective
studies, particularly focusing on the early outcome after
EVTA in larger veins (with a diameter >10 or >12 mm), no
difference could be found in efﬁcacy (obliteration rate)
between these larger veins and those with a smaller
diameter.24,25
In the case of a small diameter of the reﬂuxing GSV
almost one-third of participants indicated they would pro-
ceed to UGFS of the GSV and/or tributaries, or single
phlebectomies without GSV ablation. One large prospective
study demonstrated that UGFS of saphenous veins is more
efﬁcient in veins smaller than 6 mm diameter than in those
with larger diameters.26 Single phlebectomy has been
investigated in two prospective studies, which showed
abolition of reﬂux after single phlebectomies in the case of
smaller diameter GSVs, a short reﬂuxing GSV segment,
clinical class C2, and relatively low impact of CVD on HRQoL
before treatment.27,28
This study has a number of limitations. First of all, char-
acteristics of non-responders were not recorded. Therefore,
the authors were not able to exclude the presence of a
selection bias. Second, as the survey was only available in
English and Spanish, difﬁculties with the language may have
been an issue. Third, two important participant character-
istics were not recorded: work setting (hospital or private
practice) and reimbursement of phlebologic care in country
of present practice. These characteristics might have inﬂu-
enced the variety of treatment preferences.
In conclusion, this study illustrates theworldwide variety in
management preferences for treating patients with varicose
veins (C2eC6). In clinical practice, patient related and DUS
related factors clearly inﬂuence therapeutic options.ACKNOWLEDGEMENTS
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